Document 0439 DOCN M9590439 TI Natural protection against HIV-1 infection provided by HIV-2 [see comments] DT 9509 AU Travers K; Mboup S; Marlink R; Gueye-Nidaye A; Siby T; Thior I; Traore I; Dieng-Sarr A; Sankale JL; Mullins C; et al; Department of Cancer Biology, Harvard School of Public Health,; Boston, MA 02115, USA. SO Science. 1995 Jun 16;268(5217):1612-5. Unique Identifier : AIDSLINE MED/95296692 CM Comment in: Science 1995 Jun 16;268(5217):1566 AB Significant differences have been observed in the rates of transmission and disease development in human immunodeficiency virus (HIV) types 1 and 2. Because many HIV-2-infected people remain asymptomatic for prolonged periods, the hypothesis that HIV-2 might protect against subsequent infection by HIV-1 was considered. During a 9-year period in Dakar, Senegal, the seroincidence of both HIV types was measured in a cohort of commercial sex workers. Despite a higher incidence of other sexually transmitted diseases (STDs), HIV-2-infected women had a lower incidence of HIV-1 than did HIV-seronegative women, with a relative risk of 0.32 (P = 0.008). An understanding of the cross-protective mechanisms involved may be directly relevant to HIV-1 vaccine development. DE Antigenic Determinants/IMMUNOLOGY AIDS Vaccines Cohort Studies Confounding Factors (Epidemiology) Cross Reactions CD4 Lymphocyte Count Female Human HIV Antigens/IMMUNOLOGY HIV Infections/EPIDEMIOLOGY/*IMMUNOLOGY/PREVENTION & CONTROL/ VIROLOGY HIV Seropositivity HIV-1/*IMMUNOLOGY/PATHOGENICITY HIV-2/*IMMUNOLOGY/PATHOGENICITY Immunity, Natural Multivariate Analysis Prospective Studies Prostitution Regression Analysis Senegal Support, U.S. Gov't, Non-P.H.S. Support, U.S. Gov't, P.H.S. Virulence JOURNAL ARTICLE SOURCE: National Library of Medicine. NOTICE: This material may be protected by Copyright Law (Title 17, U.S.Code).